Clinical and antibody characteristics reveal diverse signatures of severe and non-severe SARS-CoV-2 patients.

Hongye WangDongshan YanYa LiYanfei GongYulin MaiBingxiang LiXiaoyong ZhuXinrui WanLiyun XieHuaKe JiangMin ZhangMing SunYufeng YaoYongzhang Zhu

Published in: Infectious diseases of poverty (2022)

Antibody detection provides important clinical information in the COVID-19 process. The different signatures in Ig isotypes, IgG subclasses, antibody specificity between the COVID-19 severe and non-severe group will contribute to future therapeutic and preventive measures development.

Keyphrases

sars cov
coronavirus disease
early onset
end stage renal disease
genome wide
newly diagnosed
respiratory syndrome coronavirus
chronic kidney disease
healthcare
dna methylation
peritoneal dialysis
gene expression
current status
health information
quantum dots